Fundraising Fox

LeukoDx

San Jose, US · Maryland corporation

Biotech

Founders & leadership

NN
Nir NimrodiExecutive

Board

BZ
Barry ZubrowBoard director
SH
Steve HurvitzBoard director
MC
Mark ChessBoard director
BS
Bruce SholkBoard director
CP
Charles PiazzaBoard director
MR
Michael ReynierBoard director

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2020

▶$5MraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce SholkDirector
  • Barry ZubrowDirector
  • Charles PiazzaDirector
  • Michael ReynierDirector
  • Steve HurvitzDirector
  • Mark ChessDirector
  • Nir NimrodiDirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$5M
First sale
Jul 2020
Incorporated
Corporation, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

LeukoDx, GE Healthcare Enter Agreement | Technology Networkstechnologynetworks.com · Mar 2016LeukoDx and GE Healthcare Enter Agreement to Explore Solutions for Cell Characterization in Cell Therapy Manufacturingglobenewswire.com · Mar 2016LeukoDx attracts $7 mln funding | PE Hubpehub.com · Jun 2014LeukoDx Inc. Closes $7M Financing Round; Appoints Seymour Liebman & Mark Chess to BODfinance.yahoo.com · Jun 2014LeukoDx Secures Investment Commitments of up to $8 Million, Closes on the First Tranche of $1.6 Million - BioSpacebiospace.com · Apr 2012LeukoDx 6/16/2014 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

How much funding has LeukoDx raised?
LeukoDx has disclosed $5M raised across 1 round.
Where is LeukoDx headquartered?
LeukoDx is headquartered in San Jose, US.